Biotech workforce ecosystem coming full circle in Bradenton area

Posted by on Nov 24, 2014 in Newsroom | 0 comments

BRADENTON, FL. – When Laila Abdullah, a researcher at the Bradenton area’s Roskamp Institute, won a nearly $1 million grant to study Gulf War illness, it was a major success in the young woman’s life and the institute’s programs. It also signaled a success for the region’s biotech industry, where creating a path for developing and retaining talent is a key to attracting and growing businesses that offer high-wage careers. Abdullah graduated from a high school in Orlando, then the University of South Florida in Tampa, and ultimately earned her doctorate degree in...

Read More

Huntsville’s innovators and inventors need a permanent funding source: opinion

Posted by on Nov 24, 2014 in Newsroom | 0 comments

HUNTSVILLE, AL. – Take a stroll through the U.S. Space & Rocket Center’s new exhibit, “101 Rocket City Inventions,” and you get a quick reminder that innovation is infused into Huntsville’s DNA. From the airplane design patented by William Quick in 1908 to to Wernher von Braun’s 1961 patent for the “rocket-propelled missile” that paved the way for the Saturn V, Huntsville’s role in aerospace innovation is well-documented. But it’s not just rockets and missiles that have been developed here. Intergraph pioneered computer...

Read More

Georgia company to acquire UM Tissue Bank assets

Posted by on Nov 20, 2014 in Newsroom | 0 comments

MARIETTA, GA. and MIAMI, FL. – The University of Miami’s Tissue Bank will turn over proprietary technology to a Georgia-based biotechnology company, the university announced Wednesday. Vivex Biomedical will work with UM, aiming to expand manufacturing and distribution agreements for regenerative tissue products. “The University of Miami’s Tissue Bank has designed and manufactured tissue products that make a difference in people’s lives,” UM CFO Joe Natoli said in a news release. “In Vivex, we have the right industry ally to carry on the tradition of...

Read More

Argos Aims To Automate Cell-Based Cancer Therapy

Posted by on Nov 20, 2014 in Newsroom | 0 comments

DURHAM, N.C. – Eventually, someone is going to have clinical and commercial success with a personalized cancer therapy. Learning from the mistakes of Dendreon and others, Argos expects to be first. Automation is its key. Argos Therapeutics has developed a cell-based therapy to help the body’s own immune system fight cancer already present, on a tumor-specific and patient-specific basis. The Arcelis platform technology can, in theory, boost immune response to many kinds of solid tumors. Argos aims to prove its worth, first as an add-on to standard-of-care treatment for advanced...

Read More

GTx Announces $43.4 Million Private Placement

Posted by on Nov 11, 2014 in Newsroom | 0 comments

MEMPHIS, TN. – GTx, Inc. announced on November 10th, that it has entered into a securities purchase agreement for the sale of approximately $43.4 million of its common stock and warrants to purchase common stock in a private placement. The group of accredited investors includes Biotechnology Value Fund, L. P. and other affiliates of BVF Partners L.P., certain existing GTx stockholders and certain members of the GTx management team and board of directors. Pursuant to the terms of the securities purchase agreement, at the closing of the private placement, GTx will receive approximately...

Read More

SCRA Technology Ventures Announces Funding

Posted by on Nov 9, 2014 in Newsroom | 0 comments

COLUMBIA, S.C. – SCRA Technology Ventures announced November 7th, that Client Company PPI Pharmaceuticals has received Small Business Technology Transfer (STTR) matching funds from the SC Launch program. The funds will help the Columbia-based company develop targeted oncology therapeutics. “We are delighted to support PPI Pharmaceuticals through this STTR match” The company was formed by Dr. Campbell McInnes of the University of South Carolina, based on discoveries from his laboratory. PPI’s technology allows for more efficient pharmaceutical development against targets...

Read More